UK biotech firm Acambis has decided to bring the manufacturing of
its soon to be approved smallpox vaccine in-house while its
agreement with contract manufacturer Baxter comes to an end.
Albany Molecular Research (AMRI) has followed up its push into new
markets for its drug discovery operations by tapping into the
well-established trend for sourcing contract pharmaceutical
manufacturing from the lower-cost Asian region.
Thailand is the first recipient of six major grants the World
Health Organization (WHO) is distributing to developing countries
to establish in-country manufacturing capacity for influenza
vaccine.
Swiss contract manufacturer Lonza has decided to merge its US
microbial biopharma business activities in a single location, three
months after buying Cambrex's biopharma unit.
US contract manufacturer Albemarle has announced it will move
operations of its pilot plant in Ohio to its recently acquired
manufacturing facility in Michigan.
After months of speculation and bartering following Merck KGaA's
decision to put its generics arm up for sale, the winning bid has
finally been announced, with US firm Mylan Laboratories emerging
victorious beating off the competition...
Clariant has cut its ties with the life sciences industry and will
no longer offer custom manufacturing services in this arena after
the sale of the last piece of its Lifesciences division.
An online database detailing information on all manufacturing and
importation certificates and authorisations issued within the
European medicines network has been launched by the European
Medicines Agency (EMEA).
US contract manufacturer PharmaFab has agreed to stop the
manufacturing and distribution of some of its drugs after
regulators found they were produced illegally.
Roche gave an update on its manufacturing of influenza drug Tamiflu
(oseltamivir) today, saying that while it had reached its target
capacity of 400 million doses a year, demand is running much lower.
Outsourcing is key for pharma companies and medical device
manufacturers keen to develop and produce "combination products" -
medical devices embedded with a pharma component - according to an
industry player.
Discovery Laboratories has announced that a shareholder lawsuit
filed against the company was dismissed by a Pennsylvania court,
marking the end of its two-year manufacturing nightmare.
Shire Pharmaceuticals' plans to buy New River Pharmaceuticals will
eventually affect a contract manufacturing arrangement with Albany
Molecular Research (AMR).
Indian chemical firm Syschem is planning to splash out up to $15m
(€11.4m) over two years to expand its manufacturing capacity – a
move the company said will facilitate its smooth entry into the
pharma industry and help cope with...
Actavis has waded further into India and picked up new contract
manufacturing capabilities along the way with the purchase of a
division of Sanmar Specialty Chemicals (SSCL).
Italian contract manufacturer Procos has just opened a US office -
a move that will allow the company to offer custom synthesis
services directly to its US customers.
This week Lonza took over the reigns of two new US business units
from Cambrex after completing the largest acquisition in its
company history and also announced a capability expansion at its
Czech Republic site.
Pfizer's latest cutbacks will provide a new outsourcing opportunity
for contract manufacturing organisations (CMOs) in low-cost
destinations as the drug giant announces plans to double its amount
of drug production outsourcing.
Johnson Matthey has announced a reassuring business update ahead of
its 31 March year-end, suggesting that Adderall is the driving
force behind a recovery in its pharmaceutical materials business.
A multi-million dollar US manufacturing contract for Acambis hinges
on whether or not the firm can satisfy the Food and Drug
Administration (FDA) that its investigational smallpox vaccine
should be approved.
A new Special Economic Zone (SEZ) is being created by Indian firm
JB Chemicals & Pharmaceuticals for the contract manufacturing
of active pharmaceutical ingredients (APIs), intermediates and
finished drug formulations.
India's drug manufacturing industry is tipped to grow 10 per cent
over the next three years as more pharma firms shift operations
there to cut costs, says a research report.
India's Dishman Pharmaceuticals & Chemicals is planning to snap
up biotech and nanotech contract research organisation (CRO)
companies in Europe and in the US within drug conjugates to expand
their biologics capability.
Dr Reddy's Laboratories has boosted its ability to serve Western
pharmaceutical markets with an increase in its manufacturing
capacity for drug formulations.
Swiss custom manufacturer Lonza and Singapore's BioOne Capital have
announced a new joint venture to build a $350m (€263m) large-scale
manufacturing facility in Singapore.
Dutch biotech company Crucell said last week that it had completed
its acquisition of SBL Vaccin in an agreement worth €39.4m, but
remained tight-lipped about its plans for the Swedish firm's
contract manufacturing business.
Singapore has successfully completed the first phase of its
biomedical science (BMS) initiative and is now pushing the second
phase forward in order to drive growth in its pharma industry
further.
International drug firms are increasingly turning to Taiwan for the
low-cost made-to-order processing of active pharmaceutical
ingredients (APIs), according to the Taiwan External Trade
Development Council (TAITRA).
DSM Biologics, the biopharma arm of DSM group, has signed a
manufacturing deal with Japanese UMN Pharma based on the firm's
novel recombinant protein manufacturing platform.
Although manufacturing is the most established of the pharma
outsourcing segments, many service areas are still rapidly
evolving. OutsourcingPharma.com gives a brief run down of the
current state of play.
UK Biopharma company Evolutec has signed a deal with Wacker Biotech
to produce Evolutec's new autoimmune disease drug candidate rEV576
for clinical trials.
Service provider Saltigo is reinforcing its position in the
stabilising fine chemical custom manufacturing industry by
investing in the expansion of its German facility.
Firms engaging in both in-house and contract pharma manufacturing
generally display inferior performance compared to manufacturers
conducting only in-house production, according to new research.
Sigma-Aldrich Group member SAFC made its presence felt at the
recent CPhI in Paris with announcements regarding its expansion
activities in transgenic manufacturing and India.
Pfizer CentreSource has decided to outsource the manufacture of some of its active pharmaceutical ingredients (API) to two Asian contract manufacturers and intends to work with the Food and Drug Administration's (FDA) during the process.
Cardinal Health says it is experiencing a "robust market" for its
cell line engineering technology, as it attracts the attention of
pharma giant Wyeth and executes capacity expansion plans its for
full service offerings...
Indena offers custom development by leveraging the expertise of a specialized team devoted to designing and developing processes and analytical methods....
